Novavax Inc. buy BTIG Research
Start price
28.02.25
/
50%
€6.81
Target price
28.02.26
€18.25
Performance (%)
22.38%
End price
01.03.26
€8.34
Summary
This prediction ended on 01.03.26 with a price of €8.34. The prediction had a final performance of 22.38%. BTIG_Research has a follow-up prediction for Novavax Inc. where he still thinks Novavax Inc. is a Buy. BTIG_Research has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Novavax Inc. | 8.189% | 8.189% | -8.862% |
| iShares Core DAX® | 2,57 % | 3,50 % | 8,41 % |
| iShares Nasdaq 100 | 4,86 % | 0,65 % | 28,38 % |
| iShares Nikkei 225® | 5,59 % | -0,25 % | 52,92 % |
| iShares S&P 500 | 3,25 % | 2,08 % | 24,37 % |
Comments by BTIG_Research for this prediction
In the thread Novavax Inc. diskutieren
Novavax, Inc. (NASDAQ: NVAX) is now covered by analysts at BTIG Research. They set a "buy" rating and a $19.00 price target on the stock.
Ratings data for NVAX provided by MarketBeat
In the thread Trading Novavax Inc.
Die von BTIG_Research gewählte maximale Laufzeit wurde überschritten